MELVILLE, N.Y.--(BUSINESS WIRE)--OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) announced today that Colin Goddard, Ph.D., Chief Executive Officer of OSI Pharmaceuticals, will present at the Merrill Lynch Conference in New York, NY on Tuesday, February 5, 2008 at 8:00am (Eastern Standard Time). Dr. Goddard will provide an overview on the Company’s product portfolio and business developments.
